ncRNA-mediated fatty acid metabolism reprogramming in HCC

Trends Endocrinol Metab. 2023 May;34(5):278-291. doi: 10.1016/j.tem.2023.02.007. Epub 2023 Mar 6.

Abstract

The challenges of hepatocellular carcinoma (HCC) pathogenesis, diagnosis, treatment, and prognosis evaluation are obvious. Hepatocyte-specific fatty acid (FA) metabolic reprogramming is an important marker of liver carcinogenesis and progression; elucidating its mechanism will help unravel the complexity of HCC pathogenesis. Noncoding RNAs (ncRNAs) play important roles in HCC development. Moreover, ncRNAs are important mediators of FA metabolism and are directly involved in the reprogramming of FA metabolism in HCC cells. Here we review significant new advances in understanding the mechanisms regulating HCC metabolism by focusing on ncRNA-mediated post-translational modifications of metabolic enzymes, metabolism-related transcription factors, and other proteins in associated signaling pathways. We also discuss the great therapeutic potential of targeting ncRNA-mediated FA metabolism reprogramming in HCC.

Keywords: hepatocellular carcinoma; metabolic reprogramming; noncoding RNA; tumor metabolic microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / diagnosis
  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / metabolism
  • Fatty Acids
  • Humans
  • Lipid Metabolism
  • Liver Neoplasms* / diagnosis
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / metabolism
  • RNA, Untranslated / genetics
  • RNA, Untranslated / metabolism

Substances

  • RNA, Untranslated
  • Fatty Acids